Baricitinib set to join the Covid-19 therapeutic arsenal? (2021)
Attributed to:
mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 – Repurposed Drugs (TACTIC-R)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keab061
PubMed Identifier: 33502499
Publication URI: http://europepmc.org/abstract/MED/33502499
Type: Journal Article/Review
Volume: 60
Parent Publication: Rheumatology (Oxford, England)
Issue: 4
ISSN: 1462-0324